Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gap Coverage For Brand Drugs Urged In Draft Call Letter For 2008 Part D Plans

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS’ Abby Block says the agency wants increased numbers of Part D plans offering preferred brands as well as generic coverage in the donut hole.

You may also be interested in...

CIGNA's Limited Brand Coverage In Part D Gap Emphasizes Challenges

After several years of no national Medicare Part D prescription drug plan sponsors offering any kind of brand drug coverage in the donut hole, CIGNA's "Medicare Rx Plan Three" product offering in 2010 will give seniors suffering from hypothyroidism that option

ICER Partnering With Aetion To Scale Up Use Of RWE In Value Assessments

Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts